A Digital Smoking Cessation Intervention for Cancer Survivors: Analysis of Predictors and Moderators of Engagement and Outcome alongside a Randomized Controlled Trial (Preprint)

Author:

Andree RosaORCID,Mujcic AjlaORCID,den Hollander WouterORCID,van Laar MargrietORCID,Boon BrigitteORCID,Engels RutgerORCID,Blankers MatthijsORCID

Abstract

BACKGROUND

Recent studies have shown positive, though small clinical effects of digital smoking cessation (SC) interventions for cancer survivors. However, research on associations between participant characteristics, intervention engagement, and outcomes is limited.

OBJECTIVE

The aim of this study was to explore predictors and moderators of engagement and outcome of ‘MyCourse Quit Smoking’(in Dutch: ‘MijnKoers Stoppen met Roken’), a digital minimally guided intervention for cancer survivors.

METHODS

A secondary analysis of data from the randomized controlled trial was performed. The number of cigarettes smoked in the past 7 days at 6-month follow-up was the primary outcome measure. We analyzed interactions between participant characteristics (eleven variables), intervention engagement (three variables), and outcome using Robust Linear (Mixed) Modelling.

RESULTS

In total, 165 participants were included in our study. Female participants accessed the intervention less often than men (B=-11.12, p=.004). A higher Alcohol Use Disorders Identification Test (AUDIT) score at baseline was associated with a significantly higher number of logins (B=1.10, p<.001) and diary registrations (B=1.29, p<.001). A higher Fagerström Test for Nicotine Dependence (FTND) score at baseline in the intervention group was associated with a significantly larger reduction in tobacco use after 6 months (B=-9.86, p=.002). No other associations and no moderating effects were found.

CONCLUSIONS

Overall, a limited number of associations was found between participant characteristics, engagement and outcome, except for gender, problematic alcohol use, and nicotine dependence. Future studies are needed to shed light on how this knowledge can be used to improve the effects of digital SC programs for cancer survivors.

CLINICALTRIAL

The Netherlands Trial Register NTR6011; https://www.trialregister.nl/trial/5434

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3